Beatrice A. Golomb, MD, PhD; Laura C. Erickson, BS; Sabrina Koperski, BS; Deanna Sack, BS; Murray Enkin, MD; Jeremy Howick, PhD
No regulations govern placebo composition. The composition of placebos can influence trial outcomes and merits reporting.
To assess how often investigators specify the composition of placebos in randomized, placebo-controlled trials.
4 English-language general and internal medicine journals with high impact factors.
3 reviewers screened titles and abstracts of the journals to identify randomized, placebo-controlled trials published from January 2008 to December 2009.
Reviewers independently abstracted data from the introduction and methods sections of identified articles, recording treatment type (pill, injection, or other) and whether placebo composition was stated. Discrepancies were resolved by consensus.
Most studies did not disclose the composition of the study placebo. Disclosure was less common for pills than for injections and other treatments (8.2% vs. 26.7%; P = 0.002).
Journals with high impact factors may not be representative.
Placebos were seldom described in randomized, controlled trials of pills or capsules. Because the nature of the placebo can influence trial outcomes, placebo formulation should be disclosed in reports of placebo-controlled trials.
University of California Foundation Fund 3929—Medical Reasoning.
Golomb BA, Erickson LC, Koperski S, Sack D, Enkin M, Howick J. What's in Placebos: Who Knows? Analysis of Randomized, Controlled Trials. Ann Intern Med. 2010;153:532–535. doi: 10.7326/0003-4819-153-8-201010190-00010
Download citation file:
Published: Ann Intern Med. 2010;153(8):532-535.
Research and Reporting Methods.
Results provided by:
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use